1. Home
  2. BSX vs BLK Comparison

BSX vs BLK Comparison

Compare BSX & BLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • BLK
  • Stock Information
  • Founded
  • BSX 1979
  • BLK 1988
  • Country
  • BSX United States
  • BLK United States
  • Employees
  • BSX N/A
  • BLK N/A
  • Industry
  • BSX Medical/Dental Instruments
  • BLK Investment Bankers/Brokers/Service
  • Sector
  • BSX Health Care
  • BLK Finance
  • Exchange
  • BSX Nasdaq
  • BLK Nasdaq
  • Market Cap
  • BSX 120.7B
  • BLK 114.2B
  • IPO Year
  • BSX 1992
  • BLK 1999
  • Fundamental
  • Price
  • BSX $81.60
  • BLK $866.94
  • Analyst Decision
  • BSX Strong Buy
  • BLK Strong Buy
  • Analyst Count
  • BSX 21
  • BLK 14
  • Target Price
  • BSX $85.24
  • BLK $898.43
  • AVG Volume (30 Days)
  • BSX 4.3M
  • BLK 422.2K
  • Earning Date
  • BSX 10-24-2024
  • BLK 10-11-2024
  • Dividend Yield
  • BSX N/A
  • BLK 2.35%
  • EPS Growth
  • BSX 104.77
  • BLK 17.64
  • EPS
  • BSX 1.23
  • BLK 40.29
  • Revenue
  • BSX $15,229,000,000.00
  • BLK $18,686,000,000.00
  • Revenue This Year
  • BSX $15.44
  • BLK $13.22
  • Revenue Next Year
  • BSX $10.84
  • BLK $11.55
  • P/E Ratio
  • BSX $66.49
  • BLK $21.52
  • Revenue Growth
  • BSX 13.65
  • BLK 7.68
  • 52 Week Low
  • BSX $48.35
  • BLK $596.18
  • 52 Week High
  • BSX $82.47
  • BLK $903.46
  • Technical
  • Relative Strength Index (RSI)
  • BSX 66.25
  • BLK 49.70
  • Support Level
  • BSX $80.50
  • BLK $878.70
  • Resistance Level
  • BSX $82.47
  • BLK $903.46
  • Average True Range (ATR)
  • BSX 1.12
  • BLK 13.63
  • MACD
  • BSX 0.25
  • BLK -2.27
  • Stochastic Oscillator
  • BSX 81.79
  • BLK 26.52

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About BLK BlackRock Inc.

BlackRock is the largest asset manager in the world, with $10.473 trillion in assets under management at the end of March 2024. Its product mix is fairly diverse, with 54% of managed assets in equity strategies, 27% in fixed income, 9% in multi-asset classes, 7% in money market funds, and 3% in alternatives. Passive strategies account for around two thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which by our calculations account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one third of managed assets coming from investors domiciled outside the US and Canada.

Share on Social Networks: